Premium
Evaluation of the use of prolution‐depot (hydroxyprogesterone hexanoate) in early pregnancy
Author(s) -
Varma T.R.,
Morsman John
Publication year - 1982
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(82)90039-x
Subject(s) - medicine , pregnancy , depot , gestation , adverse effect , obstetrics , fetus , gynecology , genetics , archaeology , biology , history
This study evaluates the effect of treatment with Proluton‐Depot (hydroxyprogesterone hexanoate) in early pregnancy, and the final outcome of pregnancy and fetal status. One hundred and fifty patients received intramuscular injection of Proluton‐Depot from 6 weeks to 8 weeks to 16 weeks to 18 weeks gestation. The outcome of this treated group was compared with a similar number of 150 patients with similar problems, but the second group received no hormonal treatment. There was no evidence to suggest that Proluton‐Depot had any adverse effect on the infant or the final outcome of pregnancy.